We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in prec... Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.19 | 7.53968253968 | 2.52 | 2.98 | 2.5 | 149180 | 2.75790224 | CS |
4 | 0.39 | 16.8103448276 | 2.32 | 2.98 | 2.25 | 129955 | 2.63974179 | CS |
12 | 0.5 | 22.6244343891 | 2.21 | 2.98 | 1.98 | 132347 | 2.39857323 | CS |
26 | 0.67 | 32.8431372549 | 2.04 | 4.2684 | 1.98 | 164197 | 2.8905434 | CS |
52 | 0.86 | 46.4864864865 | 1.85 | 4.2684 | 1.555 | 113902 | 2.61181318 | CS |
156 | -1.23 | -31.2182741117 | 3.94 | 4.2684 | 1.02 | 104938 | 2.26250364 | CS |
260 | -0.88 | -24.5125348189 | 3.59 | 5.7 | 1.02 | 385896 | 2.96039435 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions